首頁 > 市場調查報告書 > 製藥

生物製藥分析測試服務市場規模、佔有率和成長分析（按分子類型、測試類型、工作流程、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1897240

生物製藥分析測試服務市場規模、佔有率和成長分析（按分子類型、測試類型、工作流程、應用、最終用戶和地區分類）—2026-2033年產業預測

Biopharmaceutical Analytical Testing Services Market Size, Share, and Growth Analysis, By Molecule Type, By Test Type, By Workflow, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 249 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，生物製藥分析測試服務市場規模將達到 85.7 億美元，到 2025 年將達到 91.2 億美元，到 2033 年將達到 149.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.36%。

生物製藥分析檢測服務市場對於治療性蛋白質和化合物的成功開發至關重要。先進的分析方法在藥物發現的整個過程中提供重要的分子資訊，包括申報監測、生物程序最佳化和藥物釋放測試。隨著生物治療藥物日益複雜，先進的分析技術對於闡明其結構和活性以及識別雜質的至關重要。隨著生物製藥研發的擴展，越來越多的分析工具湧現，提高了檢測具有治療潛力的潛在藥物標靶的能力。生命科學產業在疫情後復甦，進一步刺激了對這些關鍵服務的需求，鞏固了北美及其他地區的市場成長前景。

生物製藥分析測試服務市場按分子類型、測試類型、工作流程、應用領域、最終用戶和地區進行細分。依分子類型分類，市場分為小分子和大分子。依測試類型分類，市場分為ADME（吸收、分佈、代謝和排泄）、藥物動力學（PK）、動態（PD）、生物利用度、生物等效性及其他。依工作流程分類，市場分為樣品製備與樣品分析。依應用領域分類，市場分為腫瘤學、神經病學、心臟病學、感染疾病及其他。按最終用戶分類，市場分為製藥和生物技術公司、受託研究機構（CRO）、學術和研究機構及其他。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

生物製藥分析測試服務市場的成長要素

推動生物製藥分析檢測服務業成長的關鍵因素之一是丙烯腈-甲基丙烯酸甲酯-丁二烯苯乙烯（AMMBS）需求的不斷成長。這一成長主要歸因於丙烯腈-甲基丙烯酸甲酯全球市場的擴張，該材料在免疫療法中發揮關鍵作用，能夠增強身體對多種疾病的免疫反應。針對類風濕性關節炎和癌症等疾病的抗體研發投入也不斷增加。此外，癌症治療領域的創新方法包括精準腫瘤靶向，從而實現更有效的治療。對這些特殊療法的日益關注，也推動了生物製藥產業對分析檢測服務需求的成長。

生物製藥分析測試服務市場的限制因素

測試和分析不足可能導致產品因未能達到必要的監管標準而出現嚴重缺陷。如果產品不符合這些基本要求，公司可能會遭受重大經濟損失，並且可能難以重新啟動或重新評估其藥物測試流程。這種限制不僅阻礙了公司將有效療法推向市場的能力，而且還會威脅到公司的聲譽和業務永續營運。因此，分析測試服務不足帶來的風險是限制生物製藥分析測試服務市場成長的一大阻礙因素。

生物製藥分析測試服務市場趨勢

生物製藥分析檢測服務市場呈現強勁的上升趨勢，這主要得益於研發投入的不斷成長，尤其是在新興經濟體。推動這一成長勢頭的，是對先進檢測解決方案日益成長的需求，以確保生物製藥產品的有效性和安全性。隨著開發中國家不斷加強實驗室基礎設施和研發能力，分析檢測領域的服務供應商迎來了新的機會。此外，監管審查的日益嚴格以及對創新治療方法需求的成長，進一步推高了對專業檢測服務的需求，從而鞏固了市場的成長勢頭。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Eurofins Scientific
Charles River Laboratories
WuXi AppTec
SGS SA
Laboratory Corporation of America Holdings（LabCorp）
IQVIA
Medpace
Intertek Group
Syneos Health
ICON plc
Frontage Laboratories
PPD（Pharmaceutical Product Development）
PAREXEL International
Almac Group
Celerion
Altasciences
BioAgilytix Labs
Lotus Labs
LGS Limited
Sartorius AG

結論與建議

簡介目錄

Product Code: SQMIG35H2168

Biopharmaceutical Analytical Testing Services Market size was valued at USD 8.57 Billion in 2024 and is poised to grow from USD 9.12 Billion in 2025 to USD 14.93 Billion by 2033, growing at a CAGR of 6.36% during the forecast period (2026-2033).

The biopharmaceutical analytical testing services market is pivotal for the successful development of therapeutic proteins and compounds. Advanced analytical methods provide essential molecular insights that inform the entire drug discovery process, encompassing applicant monitoring, bioprocess optimization, and drug release testing. The increasing complexity of biotherapeutics necessitates sophisticated analytical technologies to elucidate their structures and activities, as well as identify impurities. As research and development in biopharmaceuticals expand, a diverse array of analytical tools continues to emerge, enhancing the detection of promising drug targets with significant therapeutic potential. The revival of life sciences operations following disruptions has further stimulated demand for these vital services, solidifying the market's growth prospects in North America and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopharmaceutical Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopharmaceutical Analytical Testing Services Market Segments Analysis

Biopharmaceutical Analytical Testing Services Market is segmented by molecule type, test type, workflow, application, end user and region. Based on molecule type, the market is segmented into small molecule and large molecule. Based on test type, the market is segmented into ADME (absorption, distribution, metabolism, and excretion), pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence and others. Based on workflow, the market is segmented into sample preparation and sample analysis. Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases and others. Based on end users, the market is segmented into pharmaceutical and biotechnology companies,contract research organizations (CROs), academic and research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biopharmaceutical Analytical Testing Services Market

A significant driver of growth in the biopharmaceutical analytical testing services sector is the escalating demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene. This surge is attributed to the global market's expansion for acrylonitrile methyl methacrylate, which plays a crucial role in immunotherapy by enhancing immune responses for various diseases. Research and development efforts focused on antibodies targeting conditions such as rheumatoid arthritis and cancer are increasing. Furthermore, innovative approaches in cancer treatment involve precise targeting of tumors, thereby facilitating more effective therapies. This enhanced focus on specialized treatments underscores the rising need for analytical testing services in the biopharmaceutical industry.

Restraints in the Biopharmaceutical Analytical Testing Services Market

Inadequate testing and analysis can result in significant product failures, as they may not align with the necessary regulatory standards. When products do not fulfill these essential requirements, companies face substantial financial losses and may find it challenging to resume or reassess their drug testing processes. This limitation not only hinders a company's ability to bring effective treatments to market but also jeopardizes its reputation and operational viability. As a result, the risk associated with improper analytical testing services poses a notable restraint on the growth of the biopharmaceutical analytical testing services market.

Market Trends of the Biopharmaceutical Analytical Testing Services Market

The biopharmaceutical analytical testing services market is witnessing a robust upward trend fueled by heightened investments in research and development, particularly in emerging economies. This momentum is being driven by the growing necessity for advanced testing solutions to ensure the efficacy and safety of biopharmaceutical products. As developing nations ramp up their laboratory infrastructures and research capabilities, they are creating new opportunities for service providers in the analytical testing sector. Additionally, increased regulatory scrutiny and the demand for innovative therapies are propelling the need for specialized testing services, further solidifying the market's growth trajectory.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Molecule Type & CAGR (2026-2033)

Market Overview
Small Molecule
Large Molecule

Global Biopharmaceutical Analytical Testing Services Market Size by Test Type & CAGR (2026-2033)

Market Overview
ADME (Absorption, Distribution, Metabolism, and Excretion)
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Bioavailability
Bioequivalence
Others

Global Biopharmaceutical Analytical Testing Services Market Size by Workflow & CAGR (2026-2033)

Market Overview
Sample Preparation
Sample Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Application & CAGR (2026-2033)

Market Overview
Oncology
Neurology
Cardiology
Infectious Diseases
Others

Global Biopharmaceutical Analytical Testing Services Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Others

Global Biopharmaceutical Analytical Testing Services Market Size & CAGR (2026-2033)

North America (Molecule Type, Test Type, Workflow, Application, End User)
- US
- Canada
Europe (Molecule Type, Test Type, Workflow, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Molecule Type, Test Type, Workflow, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Molecule Type, Test Type, Workflow, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Molecule Type, Test Type, Workflow, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD (Pharmaceutical Product Development)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAREXEL International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altasciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lotus Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGS Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments